SCHEMBL5740356

SCHEMBL5740356

Cc1noc2nc(CCCN(CCC(N)=O)C(=O)c3cccc(C(F)(F)F)c3)n(Cc3ccccc3)c(=O)c12

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 5/20 0.44
EDNRA P25101 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 1/20 0.35
TRPM8 Q7Z2W7 1/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
GAA P10253 1/20 0.33
CYP2C19 P33261 1/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5740352 0.81 KIF11 (0.65) KIF11
SCHEMBL6207965 0.81 KIF11 (0.56) KIF11SMN1; SMN2CYP3A4CYP2C19
SCHEMBL6206668 0.80 KIF11 (0.59) KIF11SMN1; SMN2CYP3A4CYP2C19
SCHEMBL3961772 0.80 KIF11 (0.67) KIF11CYP3A4CYP2C19
SCHEMBL5899000 0.79 KIF11 (0.54) KIF11
SCHEMBL6209044 0.77 KIF11 (0.57) KIF11MAPTHPGDRXFP1
SCHEMBL4859195 0.77 KIF11 (0.54) KIF11SMN1; SMN2LMNAPDE4APDE4B
SCHEMBL5739696 0.77 KIF11 (0.55) KIF11EDNRASMN1; SMN2PDE4APDE4B
SCHEMBL6209290 0.76 KIF11 (0.52) KIF11SMN1; SMN2PDE4APDE4BPDE4C
SCHEMBL3905973 0.74 KIF11 (0.51) KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1628981-A2 BICYCLICPYRIMIDONES AND THEIR USE TO TREAT DISEASES Bristol-Myers Squibb Company (US) 2006-03-01 EP disclosed
WO-2004106492-A2 BICYCLICPYRIMIDONES AND THEIR USE TO TREAT DISEASES BRISTOL-MYERS SQUIBB COMPANY (US) 2004-12-09 WO disclosed